Common Tobrex Side Effects


The most commonly reported Tobrex side effects (click to view or check a box to report):

Dyspnoea (5)
Eyelid Oedema (2)
Dermatitis Exfoliative (2)
Conjunctival Hyperaemia (2)
Anterior Chamber Cell (2)
Face Oedema (2)
Eye Swelling (2)
Wheezing (2)
Ocular Hyperaemia (2)
Uveitis (2)
Vision Blurred (2)
Toxic Skin Eruption (2)
Swelling Face (2)
Mouth Ulceration (1)
Lymphopenia (1)
Pco2 Decreased (1)
Nephrolithiasis (1)
Off Label Use (1)
Overdose (1)
Pallor (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Tobrex Side Effects Reported to FDA



Tobrex Side Effect Report#9917498
Ulcerative Keratitis, Eye Swelling
This is a report of a 69-year-old male patient (weight: NA) from NL, suffering from the following health symptoms/conditions: NA, who was treated with Tobrex B.i.d. (dosage: 1 Gtt, Bid, start time:
Dec 21, 2005), combined with:
  • Tamsulosine (1 Capsule, Qd)
and developed a serious reaction and side effect(s): Ulcerative Keratitis, Eye Swelling after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tobrex B.i.d. treatment in male patients, resulting in Ulcerative Keratitis side effect.
Tobrex Side Effect Report#9693082
Dermatitis Exfoliative, Febrile Convulsion
This report suggests a potential Tobrex Dermatitis Exfoliative side effect(s) that can have serious consequences. A 56-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: foreign body in eye,crohn^s disease and used Tobrex (dosage: Unk) starting
Sep 30, 2013. After starting Tobrex the patient began experiencing various side effects, including: Dermatitis Exfoliative, Febrile ConvulsionAdditional drugs used concurrently:
  • Flagyl (500 Mg, Qd)
  • Entocort (3 Mg, Qd)
  • Triflucan (Unk)
  • Smecta (1 Df, Qd)
  • Vitamin A (Unk)
The patient was hospitalized. Although Tobrex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dermatitis Exfoliative, may still occur.
Tobrex Side Effect Report#9572371
Product Packaging Issue, Foreign Body In Eye
This Product Packaging Issue problem was reported by a pharmacist from BE. A 56-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Sep 17, 2013 this consumer started treatment with Tobrex (dosage: Unk). The following drugs were being taken at the same time: NA. When using Tobrex, the patient experienced the following unwanted symptoms/side effects: Product Packaging Issue, Foreign Body In EyeThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Product Packaging Issue, may become evident only after a product is in use by the general population.
Tobrex Side Effect Report#9537614
Alopecia Areata
This Alopecia Areata side effect was reported by a health professional from FR. A 55-year-old female patient (weight:NA) experienced the following symptoms/conditions: ulcerative keratitis.The patient was prescribed Tobrex (drug dosage: Unk), which was initiated on
Feb 01, 2010. Concurrently used drugs:
  • Euronac (Unk)
  • Carteol (1 Gtt, Qd)
.After starting to take Tobrex the consumer reported adverse symptoms, such as: Alopecia AreataThese side effects may potentially be related to Tobrex.
Tobrex Side Effect Report#9399232
Eyelid Oedema, Erythema Of Eyelid
This is a report of a 56-year-old male patient (weight: NA) from HR, suffering from the following health symptoms/conditions: conjunctivitis, who was treated with Tobrex (dosage: Ou Ophthalmic, start time:
May 30, 2013), combined with: NA. and developed a serious reaction and side effect(s): Eyelid Oedema, Erythema Of Eyelid after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tobrex treatment in male patients, resulting in Eyelid Oedema side effect.
Tobrex Side Effect Report#9034706
Dermatitis Exfoliative, Toxic Skin Eruption, Face Oedema
This report suggests a potential Tobrex Dermatitis Exfoliative side effect(s) that can have serious consequences. A 93-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Tobrex (dosage: NA) starting
Aug 31, 2012. After starting Tobrex the patient began experiencing various side effects, including: Dermatitis Exfoliative, Toxic Skin Eruption, Face OedemaAdditional drugs used concurrently:
  • Lucentis ((1% Total ))
  • Levofloxacine
  • Mydriaticum
  • Tetracaine
  • Azyter
  • Neosynephrine
  • Sterdex ((1 Df Total)
The patient was hospitalized. Although Tobrex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dermatitis Exfoliative, may still occur.
Tobrex Side Effect Report#8425837-3
Swelling Face, Dermatitis Allergic, Rash Pruritic, Blister, Rash Maculo-papular
This Swelling Face problem was reported by a health professional from Czech Republic. A 4-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: eye inflammation. On
May 11, 2012 this consumer started treatment with Tobrex (dosage: (ophthalmic)). The following drugs were being taken at the same time:
  • Otobacid N
When using Tobrex, the patient experienced the following unwanted symptoms/side effects: Swelling Face, Dermatitis Allergic, Rash Pruritic, Blister, Rash Maculo-papularAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Swelling Face, may become evident only after a product is in use by the general population.
Tobrex Side Effect Report#8125965-6
Pneumonia, Anaphylactic Shock, Dyspnoea, Swelling Face
This Pneumonia side effect was reported by a physician from Israel. A male patient (weight:NA) experienced the following symptoms/conditions: eye infection.The patient was prescribed Tobrex (drug dosage: (ophthalmic)), which was initiated on NS. Concurrently used drugs:
  • Syntomycin
.After starting to take Tobrex the consumer reported adverse symptoms, such as: Pneumonia, Anaphylactic Shock, Dyspnoea, Swelling FaceThese side effects may potentially be related to Tobrex. The patient was hospitalized.
Tobrex Side Effect Report#8121537-8
Uveitis, Photophobia, Conjunctival Hyperaemia, Anterior Chamber Cell, Device Material Issue, Hypopyon
This is a report of a 55-year-old female patient (weight: NA) from Turkey, suffering from the following health symptoms/conditions: NA, who was treated with Tobrex (dosage: (every 2 Hours Ophthalmic), start time: NS), combined with:
  • Tobradex ((ophthalmic))
and developed a serious reaction and side effect(s): Uveitis, Photophobia, Conjunctival Hyperaemia, Anterior Chamber Cell, Device Material Issue, Hypopyon after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tobrex treatment in female patients, resulting in Uveitis side effect.
Tobrex Side Effect Report#8120927-7
Anterior Chamber Cell, Uveitis, Conjunctival Hyperaemia
This report suggests a potential Tobrex Anterior Chamber Cell side effect(s) that can have serious consequences. A 65-year-old male patient (weight: NA) from Turkey was diagnosed with the following symptoms/conditions: NA and used Tobrex (dosage: (every 2 Hours Ophthalmic)) starting NS. After starting Tobrex the patient began experiencing various side effects, including: Anterior Chamber Cell, Uveitis, Conjunctival HyperaemiaAdditional drugs used concurrently:
  • Tobradex ((ophthalmic))
Although Tobrex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Anterior Chamber Cell, may still occur.
Tobrex Side Effect Report#7356163-1
Fibromyalgia, Throat Irritation, Nephrolithiasis, Cataract, Injection Site Pain
This Fibromyalgia problem was reported by a consumer or non-health professional from Canada. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: cataract,crohn's disease,systemic lupus erythematosus. On
Aug 19, 2010 this consumer started treatment with Tobrex (dosage: NA). The following drugs were being taken at the same time:
  • Vitamin B-12
  • Celebrex
  • Vigamox
  • Humira
  • Nevanac Ophthalmic
  • Humira
When using Tobrex, the patient experienced the following unwanted symptoms/side effects: Fibromyalgia, Throat Irritation, Nephrolithiasis, Cataract, Injection Site PainAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Fibromyalgia, may become evident only after a product is in use by the general population.
Tobrex Side Effect Report#7322727-4
Hyperhidrosis, Off Label Use, Overdose, Epistaxis, Rhinorrhoea, Pallor, Somnolence, Blood Pressure Decreased
This Hyperhidrosis side effect was reported by a consumer or non-health professional from Brazil. A 5-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Tobrex (drug dosage: NA), which was initiated on
Oct 28, 2010. Concurrently used drugs:
  • Nasonex (Qd;nas)
  • Predsim
  • Claritin-d (4 Ml;q12h;po)
  • Amoxicillin
.After starting to take Tobrex the consumer reported adverse symptoms, such as: Hyperhidrosis, Off Label Use, Overdose, Epistaxis, Rhinorrhoea, Pallor, Somnolence, Blood Pressure DecreasedThese side effects may potentially be related to Tobrex.
Tobrex Side Effect Report#6871018-4
Corneal Oedema, Eye Injury, Eye Irritation, Eye Pruritus, Eyelid Oedema, Ocular Hyperaemia
This is a report of a 10-year-old male patient (weight: NA) from Serbia And Montenegro (see Individual Countries), suffering from the following health symptoms/conditions: eye injury, who was treated with Tobrex (dosage: Ophthalmic, start time:
Jul 02, 2010), combined with:
  • Sodium Chloride 0.9%
  • Chloramphenicol
and developed a serious reaction and side effect(s): Corneal Oedema, Eye Injury, Eye Irritation, Eye Pruritus, Eyelid Oedema, Ocular Hyperaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tobrex treatment in male patients, resulting in Corneal Oedema side effect.
Tobrex Side Effect Report#6758164-0
Dyspnoea, Eye Swelling
This report suggests a potential Tobrex Dyspnoea side effect(s) that can have serious consequences. A 46-year-old male patient (weight: NA) from Malta was diagnosed with the following symptoms/conditions: foreign body in eye and used Tobrex (dosage: Ophthalmic) starting NS. After starting Tobrex the patient began experiencing various side effects, including: Dyspnoea, Eye SwellingAdditional drugs used concurrently: NA. Although Tobrex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Tobrex Side Effect Report#6737641-2
Dry Eye, Eye Pain, Ocular Hyperaemia, Reaction To Preservatives, Vision Blurred, Visual Acuity Reduced
This Dry Eye problem was reported by a consumer or non-health professional from United States. A 76-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: conjunctivitis. On
Apr 21, 2010 this consumer started treatment with Tobrex (dosage: 1 Drop Qid Intraocular). The following drugs were being taken at the same time: NA. When using Tobrex, the patient experienced the following unwanted symptoms/side effects: Dry Eye, Eye Pain, Ocular Hyperaemia, Reaction To Preservatives, Vision Blurred, Visual Acuity ReducedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dry Eye, may become evident only after a product is in use by the general population.
Tobrex Side Effect Report#6538573-5
Aura, Vision Blurred, Visual Impairment
This Aura side effect was reported by a consumer or non-health professional from United States. A 55-year-old female patient (weight:NA) experienced the following symptoms/conditions: eye infection.The patient was prescribed Tobrex (drug dosage: Bid Otic (bid For 4 Days)), which was initiated on
Dec 10, 2009. Concurrently used drugs: NA..After starting to take Tobrex the consumer reported adverse symptoms, such as: Aura, Vision Blurred, Visual ImpairmentThese side effects may potentially be related to Tobrex.
Tobrex Side Effect Report#6003204-X
Thrombocythaemia, Toxic Skin Eruption
This is a report of a 81-year-old female patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Tobrex (dosage: Ophthalmic, start time:
Jun 13, 2008), combined with:
  • Augmentin '125'
  • Calciparine
  • Potassium Chloride
  • Zocor
  • Lercanidipine
  • Acetaminophen W/ Propoxyphene Hcl
  • Endotelon (endotelon)
  • Trandate
and developed a serious reaction and side effect(s): Thrombocythaemia, Toxic Skin Eruption after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tobrex treatment in female patients, resulting in Thrombocythaemia side effect. The patient was hospitalized.
Tobrex Side Effect Report#5929203-1
Chest Pain, Conjunctivitis, Cytolytic Hepatitis, Erysipelas, Erythema, Hypersensitivity, Keratitis, Lymphadenopathy, Lymphopenia
This report suggests a potential Tobrex Chest Pain side effect(s) that can have serious consequences. A 25-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: nasopharyngitis and used Tobrex (dosage: 1 Gtt 5x/day) starting
Sep 15, 2008. After starting Tobrex the patient began experiencing various side effects, including: Chest Pain, Conjunctivitis, Cytolytic Hepatitis, Erysipelas, Erythema, Hypersensitivity, Keratitis, Lymphadenopathy, LymphopeniaAdditional drugs used concurrently:
  • Acetaminophen
  • Rhinofluimucil (rhinofluimucil)
  • Thiovalone (thiovalone)
The patient was hospitalized. Although Tobrex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Chest Pain, may still occur.
Tobrex Side Effect Report#5794521-7
Dysphagia, Dyspnoea, Face Oedema, Mouth Ulceration
This Dysphagia problem was reported by a consumer or non-health professional from France. A 33-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: conjunctivitis. On
Mar 09, 2008 this consumer started treatment with Tobrex (dosage: Ophthalmic). The following drugs were being taken at the same time:
  • Cefpodoxime Proxetil
When using Tobrex, the patient experienced the following unwanted symptoms/side effects: Dysphagia, Dyspnoea, Face Oedema, Mouth UlcerationThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dysphagia, may become evident only after a product is in use by the general population.
Tobrex Side Effect Report#5691867-8
Blood Pressure Systolic Increased, Bronchospasm, Dyspnoea, Eosinophilia, Pco2 Decreased, Po2 Increased, Respiratory Distress, Respiratory Rate Increased, Wheezing
This Blood Pressure Systolic Increased side effect was reported by a consumer or non-health professional from Australia. A 79-year-old female patient (weight:NA) experienced the following symptoms/conditions: postoperative care.The patient was prescribed Tobrex (drug dosage: 1 Gtt Q4h Ophthalmic), which was initiated on
Jun 14, 2007. Concurrently used drugs:
  • Advantan(methylprednisolone Aceponate)
.After starting to take Tobrex the consumer reported adverse symptoms, such as: Blood Pressure Systolic Increased, Bronchospasm, Dyspnoea, Eosinophilia, Pco2 Decreased, Po2 Increased, Respiratory Distress, Respiratory Rate Increased, WheezingThese side effects may potentially be related to Tobrex. The patient was hospitalized.
Tobrex Side Effect Report#5451820-6
Dyspnoea, Wheezing
This is a report of a 80-year-old female patient (weight: NA) from Australia, suffering from the following health symptoms/conditions: prophylaxis, who was treated with Tobrex (dosage: 1 Gtt Q4h Ophthalmic, start time:
Jun 14, 2007), combined with:
  • Advantan (methylprednisolone Aceponate)
and developed a serious reaction and side effect(s): Dyspnoea, Wheezing after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tobrex treatment in female patients, resulting in Dyspnoea side effect. The patient was hospitalized.
Tobrex Side Effect Report#5196832-5
Incorrect Dose Administered
This report suggests a potential Tobrex Incorrect Dose Administered side effect(s) that can have serious consequences. A 79-year-old female patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: NA and used Tobrex (dosage: Injectable) starting NS. After starting Tobrex the patient began experiencing various side effects, including: Incorrect Dose AdministeredAdditional drugs used concurrently: NA. Although Tobrex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Incorrect Dose Administered, may still occur.



The appearance of Tobrex on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Tobrex Side Effects for Women?

Women Side Effects Reports
Dyspnoea 3
Wheezing 2
Alopecia Areata 1
Anterior Chamber Cell 1
Aura 1
Blister 1
Blood Pressure Systolic Increased 1
Bronchospasm 1
Cataract 1
Conjunctival Hyperaemia 1

What are common Tobrex Side Effects for Men?

Men Side Effects Reports
Dermatitis Exfoliative 2
Dyspnoea 2
Eye Swelling 2
Eyelid Oedema 2
Ocular Hyperaemia 2
Anaphylactic Shock 1
Anterior Chamber Cell 1
Blood Pressure Decreased 1
Chest Pain 1
Conjunctival Hyperaemia 1

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Tobrex reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Tobrex Side Effects

    Did You Have a Tobrex Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Tobrex for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Tobrex Safety Alerts, Active Ingredients, Usage Information

    NDC 0065-0643
    Type HUMAN PRESCRIPTION DRUG
    Proprietary Name Tobrex
    Name tobramycin
    Dosage Form SOLUTION
    Route OPHTHALMIC
    On market since 19810315
    Labeler Alcon Laboratories, Inc.
    Active Ingredient(s) TOBRAMYCIN
    Strength(s) 3
    Unit(s) mg/mL
    Pharma Class Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient]

    Tobrex Dosage, Warnings, Usage.

    Side Effects reported to FDA: 22

    Tobrex safety alerts: No

    Reported hospitalizations: 10

    Latest Tobrex clinical trials

    Tobrex Reviews

    No reviews, be a first to report a side effect via side effect reporting form



    © Copyright 2018 patientsville.com.